Yoshimasa Miyagawa

Yoshimasa Miyagawa

UNVERIFIED PROFILE

Are you Yoshimasa Miyagawa?   Register this Author

Register author
Yoshimasa Miyagawa

Yoshimasa Miyagawa

Publications by authors named "Yoshimasa Miyagawa"

Are you Yoshimasa Miyagawa?   Register this Author

22Publications

330Reads

16Profile Views

A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.

Anticancer Res 2019 Oct;39(10):5653-5662

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13762DOI Listing
October 2019

Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.

Breast Cancer 2019 May 16. Epub 2019 May 16.

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00977-0DOI Listing
May 2019

Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.

Mol Clin Oncol 2019 Feb 4;10(2):275-284. Epub 2018 Dec 4.

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2018.1783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327226PMC
February 2019

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.

Sci Rep 2019 Feb 12;9(1):1811. Epub 2019 Feb 12.

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-37633-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372578PMC
February 2019

High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.

J Surg Oncol 2018 Jul 24;118(1):228-237. Epub 2018 Jun 24.

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25125DOI Listing
July 2018

Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.

Breast Cancer 2017 Mar 4;24(2):245-253. Epub 2016 Apr 4.

Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0695-2DOI Listing
March 2017

Prognostic significance of preoperative F-FDG PET/CT for breast cancer subtypes.

Breast 2016 Dec 29;30:5-12. Epub 2016 Aug 29.

Division of Breast and Endocrine, Department of Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo 663-8501, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2016.08.003DOI Listing
December 2016

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.

Breast Cancer 2016 Mar 1;23(2):224-30. Epub 2014 Aug 1.

Department of Surgery, Division of Breast and Endocrine, Hyogo College of Medicine, Mukogawa 1-1, Nishinomiya, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0556-9DOI Listing
March 2016

High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.

Breast Cancer Res Treat 2015 Dec 16;154(3):521-31. Epub 2015 Nov 16.

Division of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3638-2DOI Listing
December 2015

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.

Breast Cancer 2015 Jul 6;22(4):366-73. Epub 2013 Aug 6.

Division of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0487-xDOI Listing
July 2015

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.

Clin Breast Cancer 2015 Jun 24;15(3):197-203. Epub 2014 Dec 24.

Division of Breast and Endocrine, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.12.002DOI Listing
June 2015